chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received concerning a 70 year old female patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23 (Lot # not reported). Subsequently, the patient experienced a high temperature, swelling, pain, and redness at the injection site after she received PNEUMOVAX 23. The patient's high temperature required her to take antibiotics (manufacturer unspecified). It was unknown if the patient sought medical attention. At the time of the report, the outcome of the event was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. The health care professional contacted during telephone follow-up could not supply the following information: patient's name, date of birth, dates of vaccination, lot number, date of event, or recovery status. This is one of several reports received from the same source. Additional information has been requested.
Received Tdap shot (unsure whether Adacel or Boostrix at time of filing report) on 12/04/2020 during appointment at 3:00 PM.  Tdap was indicated because I was 28 weeks pregnant at the time of the appointment.  My estimated due date is 02/24/2021 and I am currently 30 weeks pregnant at the time of this report.  When I got the shot, it didn't hurt any more than usual for any other vaccine that I have received.  Towards the evening, I started getting soreness in my arm.  By the morning of 12/05/2020, I could not move my arm very much and it was extremely sore.  I assumed it was just a normal reaction to the shot.  It seemed to get a little better over the next few days, but the pain never actually went away.  It just dulled.  On 12/12/2020, I began to become concerned because it had been a week since receiving the shot and I still was experiencing pain.  I noticed the pain was worse when I slept at night and my range of motion was becoming worse.  I tried taking Tylenol and icing the area, but the pain was only temporarily dulled.  I woke up throughout the early morning of 12/15/2020 with excruciating pain in my left shoulder and arm.  I called out of work and went to a doctor's office to be evaluated.  I was diagnosed with subacromial bursitis of the left shoulder.  Currently, I am wearing a sling to get through the work day and cannot move my arm much because it is too painful.  It is hard to function occupationally and I am having a hard time doing simple tasks, such as putting my clothes on and going to the bathroom.  I was told it would probably take weeks to heal and was referred to physical therapy in the meantime.  I am currently not sure if this will result in permanent damage or disability.  I am currently unable to perform all of my job duties and am limited to light desk work in the meantime until this injury has healed.
Pt developed fever to 105 degrees, anorexia and jerking (seizure like) movements of body for approx. 1 wk following vaccination. At 2 wks post vaccination he developed tics. (squinting and throat clearing) daytime enuresis and random complaints of pain in abdomen and genital area. Neurologist felt it was to pertussis portion of vaccine.
No additional AE/No PQC; the vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medications, concurrent conditions, medical history and drug reactions/allergies were not reported.  On 20-JAN-2022, the patient was administered with varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter (lot # U022321, expiration date: 15-JUL-2023, strength and route were unknown) after a temperature excursion for prophylaxis (product storage error). The vaccine was exposed to minus 14.1 degrees Celsius for 12 minutes. There was no previous excursion. No additional adverse event was reported.
Tinnitus worsened; This is a spontaneous report from a contactable consumer (patient Herself). A 44-year-old female consumer received first dose BNT162B2(Pfizer COVID 19 vaccine, solution for injection, lot number ER8732), via unspecified route of administration on 12Apr2021 09:00 in left arm for 1st dose, single for COVID-19 immunization. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history included ongoing high blood pressure, ongoing thyroid problems from an unspecified date of 2012, acute asthma and overweight. The patient concomitant medications was not provided. She had acute asthma and was afraid if she got COVID that she would be sick. The patient received both doses of the Pfizer COVID 19 vaccine. She reports after receiving the first dose of the vaccine on 03May2021 she had severe tinnitus and hearing loss and constant ring in the. She had a few episodes and didn't know what it was. It got a little better and then she got the second dose, and it has gotten worse after that. She saw her doctor and he mentioned that he saw lots of patients that their blood pressure and hearing were affected. Caller does not have any patient details to provide. Her doctor told her to report this, and she could go to a specialist if she wanted to. Her doctor didn't know what to do. The doctor is still documenting what his patients are telling him. She saw the doctor on Friday. He did a full blood work panel including a CBC, metabolic panel, thyroid panel. She had a full blood work panel since she has had issues. She wanted to make sure there was nothing in her blood that was alarming other than the hearing loss and tinnitus. They called this morning and said everything was normal and to report it and she can go to a specialist if she wants to. The outcome of the event was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
Patient received 2nd dose of PCV 13 on 09/12/20 which was not due and received previous dose on 05/20/20.  Patient reported no adverse side effects.
Fever up to 101 for 3 days, redness at injection site;  Then on 8/22/16 fever resolved and headache & left facial numbness/tingling extending into left arm developed and has persisted although somewhat improved.  Left arm feels sore although somewhat improved.
This spontaneous report as received from an immunization health educator refers to a child patient of an unknown age and gender. The information regarding medical history, concurrent conditions and concomitant medications was not reported. On an unknown date, the patient was inadvertently given only the sterile diluent (dose, route and site of administration, lot number and expiration date were not reported), not (manufacturer unknown) reported as HiB vaccine.
This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Diagnosed with shingles) and HEADACHE (headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. Concurrent medical conditions included Shingles (always on her back). On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced HERPES ZOSTER (Diagnosed with shingles) and HEADACHE (headache). The patient was treated with VALACYCLOVIR [VALACICLOVIR] for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Diagnosed with shingles) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. After receiving the vaccine, patient had headache, lips tingling a little bit upon touching, and then later that night the right side of her face was breaking out with blisters, went to emergency room where she was diagnosed with shingles and prescribed with Valacyclovir, and at the time of this report the patient's blisters were drying up.
Severe dizziness; This is a spontaneous report received from a contactable consumer, the patient. An 81-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN), via an unspecified route of administration in the left arm on 16Mar2021 at 14:00 (at the age of 81-years-old), as a single dose for COVID-19 immunisation. Patient did not have known allergy and did not have any other relevant medical hisotry. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN), via an unspecified route of administration in the left arm on 23Feb2021 at 16:00, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient did not receive any other medications within two weeks of vaccination. On 19Mar2021 at 02:00, the patient experienced severe dizziness on awakening. The patient did not receive any treatment for events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of severe dizziness was resolving at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
The patient presented to the clinic for a Prevnar 13 vaccine. Menactra was incidently administered. There was no adverse reaction to the vaccine for a 20min observation time in the clinic.  Patient did express feeling light-headed but was also understandably upset by the occurrance and believed she was having a minor panic attack. Her vital signs were checked and were stable, no shortness of breath or dyspnea. No signs or symptoms of an allergic reaction were noted. The patient completed an observation period and left the clinic alert, oriented and ambualtory as she arrived.
Mother states: Child had swelling & slight redness, that was warm to the touch, from the top of the left arm, down to the middle of the forearm. States symptoms developed 10/28/10. Took to doctor for treatment on 10/29/10. Doctor treated with 5 days of Prednisolone - symptoms lasted another 2-3 days. No symptoms remaining as of 11/8/10. Arm was also warm to the touch.
Janssen COVID-19 Vaccine EUA Patient verbalized fainting after prior vaccines. Patient fainted almost immediately post-vaccination. Assessed and attended at vaccination clinic site. Vital signs within normal limits. Monitored on site for 45 minutes; released with her friend.  Vaccine Clinic at a community site.
Hard swelling, itching, redness, pain at site and headache.  Started 12/28/2021
Information has been received on 06-JUN-2018 regarding a case in litigation from a lawyer and a male consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 01-DEC-2014, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In July 2016, the patient was treated at a physician's office for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient has suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Dermatagraphia - itchy skin, raised red marks wherever I scratch. I can write on my skin and it raises up to show letters. Symptoms showed up 13 days after 2nd Moderna booster.   Since 3rd shot (2nd Moderna booster) late Nov, cheeks got clown-like bright pink when exposed to heat. I thought it was new dry cold climate but now I wonder. Also, past 2 months I've experience diarrhea.
Pt recvd MMR vax on a child; pt currently exhibited a lack of response to mumps; No futher details were provided;
This spontaneous report as received from a pharmacist via RMPDC refers to a 77 year old male patient. On 22-AUG-2014, the patient was vaccinated with an expired dose of PNEUMOVAX 23 (lot # J006921, expiration date 09-AUG-2014), 0.5 ml, once injection. The patient's relevant medical history, relevant concomitant medications and past drug history were unknown. The patient received the expired dose of PNEUMOVAX 23 as the pharmacist could not read the expiration date very well. The patient did not receive a second dose of PNEUMOVAX 23. The patient's relevant tests or laboratory data was unknown. The status of expired product administration was unknown. Additional information has been requested.
Itching around elbow; Swelling around elbow; Redness; A spontaneous report was received from a Consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness, itching around elbow, swelling around elbow.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 19 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient developed Redness, Itching around elbow, Swelling around elbow.  Treatment details included Caller self administered topical medicine.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, redness,  itching around elbow, swelling around elbow was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
After basketball practice pt developed very strong pain and mild swelling at the site of the vaccine administration; pain severe enough that she is unable to move her arm at the shoulder (refuses).
Right upper arm with erythema, edema, warmth and tenderness over 2/3 circumference started on 5/13/05 then approx 4-5AM on 5/14 am several thin walled serious fluid containing blisters noted on posterior upper arm (not adjacent to injection site).
This case was reported by a pharmacist via call center representative and described the occurrence of generalized rash in a 81-year-old female patient who received SHINGRIX (batch number 9KT7T, expiry date unknown) for prophylaxis. On 12th December 2018, the patient received the 1st dose of SHINGRIX. On 13th December 2018, 1 days after receiving SHINGRIX, the patient experienced generalized rash. The patient was treated with Hydrocortisone Ointment. On an unknown date, the outcome of the generalized rash was recovered/resolved. It was unknown if the reporter considered the generalized rash to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left arm. The patient experienced a body rash after first dose of SHINGRIX. The pharmacist was unsure when rash started, it could have been the next day, but the pharmacist was not sure. The pharmacist stated the patient did not see her physician and the rash resolved after a couple weeks. The patient treated it with hydrocortisone ointment.
Nausea; Headaches; Received the second dose of the Moderna covid19 vaccine while being 17 years of age; Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the second dose of the Moderna covid19 vaccine while being 17 years of age), PAIN IN EXTREMITY (Pain in the arm), NAUSEA (Nausea) and HEADACHE (Headaches) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 014c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the second dose of the Moderna covid19 vaccine while being 17 years of age) and PAIN IN EXTREMITY (Pain in the arm). On 23-May-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (Headaches). On 22-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the second dose of the Moderna covid19 vaccine while being 17 years of age) had resolved. On 25-May-2021, PAIN IN EXTREMITY (Pain in the arm), NAUSEA (Nausea) and HEADACHE (Headaches) had resolved.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD21-090747 (Patient Link).
Vertigo started 3 weeks following second vaccination and continues to date, rash over entire body started 3 weeks after second vaccination and lasted 2 weeks
I experienced my left arm developing a cold sensation and numbness down my arm, had a skin discoloration in the area of vaccination and the skin became white and cold to touch. I became diagnosed with Parsonage Turner syndrome in my left arm.
Starting about 4 hours post vaccine I became tired with a sore throat. That evening after breastfeeding infant, infant vomited entire before bed feeding when prior infant was perfectly fine. Through the night, high fevers, chills, profuse sweating after taking Tylenol or ibuprofen.  The morning after, I became very dizzy with standing, this was an issue until 1200 pm the day after getting vaccine.  At 0800 I was getting child ready for school when suddenly felt like I was going to vomit, got to bathroom and loosed consciousness. Woke up next to toilet on floor several minutes later. I would estimate I laid there at least 5 minutes unconscious. My infant continued to not nurse well, and vomit after nursing for the day after vaccine. At 48 hours, my infant (7 months old) had very strong smelling stool, followed by diarrhea. That started last evening, 10/27/21.
Pin point rash started on bilateral forearms approx 6hrs after injection - on 4/5/12. Seen today, 4/6/12, rash around injection site, arms, chest, bilateral lower extremities.
May 8, 2018: Fever, inconsolable crying, fussy, vomiting,(May 8-May 29th) Diagnosed with fever, abdominal pain, acute gastroenterisis, febrile illness, diagnosed with ear infection then diagnosed with a virus during hospital stay. 3 weeks later diagnosed with Infant Acute Lymphoblastic Leukemia Cancer. ALL tests and records I have. Prior patient was completely healthy. We believe its due to vaccinations, and altering his DNA, because he had all tests done and no genetic reference to this either. We believe the vaccinations overloaded his system and caused the first virus. Then we believe it  lead to the leukemia.
Pt seen 24 hrs post injection, L upper arm edematous, erythema and extremely tender to touch, warm to touch, pt febrile lasting 48 hrs.
This spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 08-APR-2011, the patient was inoculated with ZOSTAVAX at a medical center as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 02-FEB-2015, the patient was treated at the same medical center for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was considered related. Additional information has been requested.
Shoulder Injury- Delayed golf ball sized induration lasting two days. Slight pain and itching also at site.
Woke up out of sleep just after 3am with pressure on chest and racing heart. Atrial fibrillation diagnosed at ER at around 4am with heart rate up to 200bpm. Medicine give for a couple of hours and then heart went back into rhythm at about 6am. Moved to ICU at around 7am and watched until I requested to be released. Was advised by Dr, cardiologist with hospital, to schedule a Echocardiogram, stress test and sleep study. Went home at about 6pm. Have and ER follow up with my PC Dr. scheduled for  4/1/22.
His blood pressure is a little high than normal for him; 99.9F temperature and now has a 101.3F temperature; Two bouts of extreme chills that last up to 20 minutes at a 30 minute interval between; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (His blood pressure is a little high than normal for him), PAIN IN EXTREMITY (Sore arm), PYREXIA (99.9F temperature and now has a 101.3F temperature) and CHILLS (Two bouts of extreme chills that last up to 20 minutes at a 30 minute interval between) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042120A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 03-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 04-Feb-2021, the patient experienced HYPERTENSION (His blood pressure is a little high than normal for him), PYREXIA (99.9F temperature and now has a 101.3F temperature) and CHILLS (Two bouts of extreme chills that last up to 20 minutes at a 30 minute interval between). At the time of the report, HYPERTENSION (His blood pressure is a little high than normal for him), PAIN IN EXTREMITY (Sore arm), PYREXIA (99.9F temperature and now has a 101.3F temperature) and CHILLS (Two bouts of extreme chills that last up to 20 minutes at a 30 minute interval between) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 99.9 (High) 99.9F temperature and 101.3 (High) 101.3F temperature.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment.  Concomitant product included medicines for high blood pressure. Treatment information was not provided.
COVID vaccine - unsure of what particular company. Vax on 8/31 - Concern for myocarditis, severe chest pain developed evening 2 days after administration, presented to ED